SAN FRANCISCO, Jan. 30 (UPI) -- Swiss pharmaceutical giant Roche said it would initiate a tender offer to take over U.S. biotechnology company Genentech.
SOUTH SAN FRANCISCO, Calif., Aug. 14 (UPI) -- Swiss pharmaceutical behemoth Roche will have to dig deeper into its pockets if it wants to own all of Genentech Inc., which rejected its $43.7 billion offer.
BASEL, Switzerland, July 21 (UPI) -- Swiss drugmaker Roche Holding AG has offered $43.7 billion -- $89 a share -- for the U.S. biotech firm Genentech.
SOUTH SAN FRANCISCO, Calif., Nov. 10 (UPI) -- Genentech Inc. has agreed to buy Houston's Tanox Inc., maker of a successful asthma medicine, in an all-cash U.S. deal worth $919 million.
SOUTH SAN FRANCISCO, Calif., Nov. 10 (UPI) -- U.S. firm Genentech has announced it will acquire Tanox, its development partner on the asthma treatment Xolair.
FOSTER CITY, Calif., Nov. 16 (UPI) -- Switzerland's Roche Holding AG settled a long-running row with Gilead Sciences Inc. over licensing of Tamiflu, seen as a key weapon against a flu pandemic.
NEW YORK, Sept. 29 (UPI) -- Genentech, Inc., a biotech company in apparent danger of having a key U.S. patent withdrawn remains well-regarded by Wall Street.
FOSTER CITY, Calif., June 24 (UPI) -- California's Gilead Sciences Inc. is pulling the license for its anti-flu drug Tamiflu from Swiss pharmaceutical giant Roche Holding AG.
BASEL, Switzerland, Jan. 14 (UPI) -- Roche Holding AG has announced the European Commission's approval of Avastin for patients with metatastic cancer of the colon or rectum.
SAN FRANCISCO, July 10 (UPI) --
